Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Fabino Life Sciences
Join Channel
Consolidated Standalone

Fabino Life Sciences

₹31.9 1.5 | 4.8%

Market Cap ₹7 Cr.

Stock P/E

P/B 1.6

Current Price ₹31.9

Book Value ₹ 19.6

Face Value 10

52W High ₹43.8

Dividend Yield 0%

52W Low ₹ 25.1

Edit Ratio

Fabino Life Sciences Research see more...

Overview Inc. Year: 2011Industry: Pharmaceuticals & Drugs

Fabino Life Sciences Ltd, a pharmaceutical organization, develops, manufactures, markets, trades in, and packages pharmaceutical and different wellness focused consumer merchandise in India. The organization offers allopathic, Covid-19, natural, veterinary, and multi diet products, in addition to food supplements. It also exports wellness and FMCG products, such as coffee, malt powder, protein powder, hair shampoo, etc. The organisation was founded in 2011 and is primarily based in Sonipat, India.

Read More..

Fabino Life Sciences Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Fabino Life Sciences Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Fabino Life Sciences Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 3 8 3 4 3
Other Income 0 0 0 0 0
Total Income 3 8 3 4 3
Total Expenditure 2 7 3 4 3
Operating Profit 0 0 0 0 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0
Profit Before Tax 0 0 0 0 0
Provision for Tax 0 0 0 0 0
Profit After Tax 0 0 0 0 0
Adjustments 0 0 0 0 0
Profit After Adjustments 0 0 0 0 0
Adjusted Earnings Per Share 0 0 0.3 0.2 0.1

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -25% -28% 0% 0%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -5% NA% NA% NA%
ROE Average 0% 2% 3% 3%
ROCE Average 1% 2% 6% 6%

Fabino Life Sciences Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 1 1 1 4 4
Minority's Interest 0 0 0 0 0
Borrowings 0 1 0 0 0
Other Non-Current Liabilities 0 0 0 0 0
Total Current Liabilities 8 2 1 0 0
Total Liabilities 9 4 2 5 5
Fixed Assets 0 0 0 0 0
Other Non-Current Assets 1 1 0 0 0
Total Current Assets 8 3 2 4 5
Total Assets 9 4 2 5 5

Fabino Life Sciences Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 0 0 1
Cash Flow from Operating Activities 0 2 -0 -2 -1
Cash Flow from Investing Activities -0 -0 -0 -0 -0
Cash Flow from Financing Activities -0 -2 0 2 0
Net Cash Inflow / Outflow 0 0 -0 1 -0
Closing Cash & Cash Equivalent 0 0 0 1 0

Fabino Life Sciences Ratios

# Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 0 0 0.25 0.22 0.05
CEPS(Rs) 0.42 1.45 0.38 0.37 0.2
DPS(Rs) 0 0 0 0 0
Book NAV/Share(Rs) 0 0 10.86 19.54 19.59
Core EBITDA Margin(%) 11.57 4.24 2.07 2.12 1.03
EBIT Margin(%) 10.66 4.01 1.61 1.7 0.75
Pre Tax Margin(%) 0.12 1.32 1.39 1.57 0.36
PAT Margin (%) 0 0.92 0.99 1.12 0.32
Cash Profit Margin (%) 0.92 1.16 1.5 1.86 1.26
ROA(%) 0 1.14 1.04 1.37 0.22
ROE(%) 0.02 10.8 3.05 1.74 0.26
ROCE(%) 9.44 12.36 2.92 2.48 0.58
Receivable days 338.15 118.63 218.18 120.1 215.29
Inventory Days 651 126.73 45.53 94.6 157.31
Payable days 1023.69 174.14 129.76 42.01 44.07
PER(x) 0 0 0 121.71 583.35
Price/Book(x) 0 0 0 1.39 1.53
Dividend Yield(%) 0 0 0 0 0
EV/Net Sales(x) 0.93 0.14 0.47 1.23 1.92
EV/Core EBITDA(x) 8.03 3.33 22.23 50.48 113.35
Net Sales Growth(%) 0 172.18 -59.32 37.39 -20.01
EBIT Growth(%) 0 2.34 -83.7 45.43 -64.52
PAT Growth(%) 0 0 -56.24 55.97 -77.04
EPS Growth(%) 0 0 -78.12 -10.9 -77.03
Debt/Equity(x) 4.17 1.61 0.24 0.01 0.1
Current Ratio(x) 1.03 1.73 3.64 10.64 10.72
Quick Ratio(x) 0.39 1.55 2.79 6.46 8.06
Interest Cover(x) 1.01 1.49 7.46 12.84 1.91
Total Debt/Mcap(x) 0 0 0 0.01 0.06

Fabino Life Sciences Shareholding Pattern

# Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024
Promoter 56.82 56.82 56.82 56.82 56.82
FII 0 0 0 0 0
DII 0 0 0 0 0
Public 43.18 43.18 43.18 43.18 43.18
Others 0 0 0 0 0
Total 100 100 100 100 100

Pros

  • Company is almost debt free.

Cons

  • Company has a low return on equity of 2% over the last 3 years.
  • Debtor days have increased from 42.01 to 44.07days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Fabino Life Sciences News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!